Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
Science Translational Medicine (2012) - Comments
pubmed: 22491949  doi: 10.1126/scitranslmed.3003651  issn: 1946-6234  issn: 1946-6242 

Jeffrey Hrkach, Daniel Von Hoff, Mir Mukkaram Mukkaram Ali, Elizaveta Andrianova, Jason Auer, Tarikh Campbell, David De Witt, Michael Figa, Maria Figueiredo, Allen Horhota, Susan Low, Kevin McDonnell, Erick Peeke, Beadle Retnarajan, Abhimanyu Sabnis, Edward Schnipper, Jeffrey J. Song, Young Ho Song, Jason Summa, Douglas Tompsett